Science & Enterprise subscription

Follow us on Twitter

  • Make me wanna shout ... #BillsMafia https://t.co/iF1vhKHXtu
    about 2 hours ago
  • First of two podcasts with experiences of news photographers in the insurrection. Thanks @cherissmay for sharing yo… https://t.co/aCjPD6ct84
    about 18 hours ago
  • Half or more of American adults express negative opinions about the way Covid-19 vaccines are distributed, accordin… https://t.co/9l2SUpW85u
    about 24 hours ago
  • New post on Science and Enterprise: Infographic – US Public Down on Vaccine Rollout https://t.co/vegz3ihvIO #Science #Business
    about 24 hours ago
  • We've written several times about Lander and his work, including companies he founded. ... Biden to Elevate Science… https://t.co/rWVGTa1gPL
    about 1 day ago

Please share Science & Enterprise

Financial Asset Managers Supporting Net Zero Emissions

Wind farm

Thirty asset managers, directing investments worth some $9 trillion, agreed to encourage their clients to achieve global net zero greenhouse gas emission goals. . . . → Read More: Financial Asset Managers Supporting Net Zero Emissions

Start-Up Creating Digital Therapies for Alzheimer’s

Brain cell networks

A new enterprise is developing personalized digital therapeutics for people with Alzheimer’s disease and other neurodegenerative disorders. . . . → Read More: Start-Up Creating Digital Therapies for Alzheimer’s

Int’l Lab Network to Assess Covid-19 Vaccines

Syringes

Six clinical testing laboratories worldwide plan to evaluate vaccines for protecting against Covid-19 infections with a common set of test protocols. . . . → Read More: Int’l Lab Network to Assess Covid-19 Vaccines

Biotechs, Univ. Labs Partner on Covid-19 Combo Therapy

Lab mouse

Two biotechnology companies are developing a Covid-19 treatment that combines engineered antibodies and natural killer immune system cells. . . . → Read More: Biotechs, Univ. Labs Partner on Covid-19 Combo Therapy

Glove-App System Translates Sign Language to Speech

Sign language translation glove

University engineers designed a glove with electronic sensors that sends signals to a smartphone app to translate American Sign Language into audible speech. . . . → Read More: Glove-App System Translates Sign Language to Speech

Covid-19 Vaccine for Lower-Income Regions Underway

Robin Shattock

Researchers in the U.K. designed a vaccine to prevent Covid-19 infections and is starting an enterprise to make it available to lower-income countries. . . . → Read More: Covid-19 Vaccine for Lower-Income Regions Underway

Industry, Univ. Labs Partner on Covid-19 Therapy

Covid-19 illustration

Researchers from industry and academic labs are developing a synthetic antibody that in lab tests shows promise as both a Covid-19 therapy and vaccine. . . . → Read More: Industry, Univ. Labs Partner on Covid-19 Therapy

Covid-19 Therapies Designed with Virtual Reality, A.I.

SARS-CoV-2 protease

Two companies are using deep learning and virtual reality to design treatments for Covid-19 infections, attacking a different target than most drugs being developed. . . . → Read More: Covid-19 Therapies Designed with Virtual Reality, A.I.

Stem Cell Therapy Licensed for Genetic Eye Disease

Red-blue-green eye

A biotechnology company is licensing its stem cell treatments for retinitis pigmentosa, an inherited eye disease, in a deal valued at $252 million. . . . → Read More: Stem Cell Therapy Licensed for Genetic Eye Disease

Venture Deals Decline in Q1, Biotech Sizzles Again

The number of venture deals declined for the third straight quarter as 2020 opened, but biotechnology remained the hottest single sector for investors. . . . → Read More: Venture Deals Decline in Q1, Biotech Sizzles Again